Kutz A, Kim DH, Wexler DJ, Liu J, et al. Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes. Diabetes Care 2023 Sep 7:dc230671. doi: 10.2337/dc23-0671.
PMID: 37677118